SCHEMBL23618378

SCHEMBL23618378

Fc1cccc(-n2c3ccccc3c3c4c(c5ccccc5n4-c4ccccc4)c4c(c5ccccc5n4-c4ccc(-c5nc(-c6ccccc6)nc(-c6ccccc6)n5)cc4)c32)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 3/20 0.41
RXFP1 Q9HBX9 1/20 0.38
APOBEC3G Q9HC16 1/20 0.38
METAP2 P50579 1/20 0.38
KDM4E B2RXH2 1/20 0.37
ATM Q13315 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
USP2 O75604 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
TSHR P16473 1/20 0.37
CYP2C19 P33261 1/20 0.37
HSD17B10 Q99714 1/20 0.37
NR3C1 P04150 1/20 0.36
TGM2 P21980 1/20 0.36
DPP4 P27487 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
ADORA2A P29274 1/20 0.36
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23618379 0.98 ABCG2 (0.42) ABCG2RXFP1APOBEC3GMETAP2KDM4E
SCHEMBL23618375 0.90 NR3C1 (0.42) ABCG2RXFP1KDM4EATML3MBTL1
SCHEMBL23618371 0.89 NR3C1 (0.43) ABCG2RXFP1KDM4EATML3MBTL1
SCHEMBL20385225 0.88 L3MBTL1 (0.47) ABCG2KDM4EATML3MBTL1ALDH1A1
SCHEMBL20385282 0.88 L3MBTL1 (0.47) ABCG2KDM4EATML3MBTL1ALDH1A1
SCHEMBL26923832 0.88 MAPT (0.47) ABCG2RXFP1KDM4ETSHRNR3C1
SCHEMBL20385320 0.87 L3MBTL1 (0.46) ABCG2KDM4EATML3MBTL1ALDH1A1
SCHEMBL20385284 0.87 L3MBTL1 (0.44) ABCG2KDM4EATML3MBTL1ALDH1A1
SCHEMBL23571975 0.87 KDM4E (0.48) RXFP1APOBEC3GMETAP2KDM4EATM
SCHEMBL23572227 0.87 KDM4E (0.48) RXFP1APOBEC3GMETAP2KDM4EATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11844272-B2 Organic electroluminescence device and polycyclic compound for organic electroluminescence device SAMSUNG DISPLAY CO., LTD. (KR) 2023-12-12 US disclosed
US-11844272-B2 Organic electroluminescence device and polycyclic compound for organic electroluminescence device SAMSUNG DISPLAY CO., LTD. (KR) 2023-12-12 US disclosed
US-20210210695-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2021-07-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210210695-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE PIEZO1, LEF1, ODC1 ABCG2 4119/4885RXFP1 3851/4885APOBEC3G 3416/4885
US-11844272-B2 Organic electroluminescence device and polycyclic compound for organic electroluminescence device PIEZO1, LEF1, ODC1 ABCG2 4119/4885RXFP1 3851/4885APOBEC3G 3416/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.